檢索結果 - Andy C. Rawstron

Refine Results
  1. 1
    Monoclonal B-cell lymphocytosis

    Monoclonal B-cell lymphocytosis 由 Andy C. Rawstron

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Assessment of minimal residual disease in myeloma and the need for a consensus approach

    Assessment of minimal residual disease in myeloma and the need for a consensus approach 由 Andy C. Rawstron, Bruno Paiva, Maryalice Stetler‐Stevenson

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria

    Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria 由 Stephen J. Richards, Andy C. Rawstron, Peter Hillmen

    出版 2000
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis

    Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis 由 Quentin A. Hill, Andy C. Rawstron, Ruth M. de Tute, Roger G. Owen

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

    Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management 由 Tait D. Shanafelt, Paolo Ghia, Mark C. Lanasa, Ola Landgren, Andy C. Rawstron

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

    Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis 由 Shouvik Dass, Andy C. Rawstron, Edward M Vital, Karen Henshaw, Dennis McGonagle, Paul Emery

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

    Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia 由 Ben Kennedy, Andy C. Rawstron, CG Carter, Mary Ryan, Kevin Speed, Guy Lucas, Peter Hillmen

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

    Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab 由 Dennis McGonagle, Ai Lyn Tan, Julie Madden, Andy C. Rawstron, Abdul Rehman, Paul Emery, Stanley Thomas

    出版 2007
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  9. 9
    Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)

    Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL) 由 Andy C. Rawstron, Tait D. Shanafelt, Mark C. Lanasa, Ola Landgren, Curtis A. Hanson, Alberto Órfão, Peter Hillmen, Paolo Ghia

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition

    Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition 由 Gururaj Arumugakani, Sophie Stephenson, Darren J. Newton, Andy C. Rawstron, Paul Emery, Gina M. Doody, Dennis McGonagle, Reuben Tooze

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus

    Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus 由 Md Yuzaiful Md Yusof, Daniel S. Shaw, Yasser M. El‐Sherbiny, Emma Dunn, Andy C. Rawstron, Paul Emery, Edward M Vital

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    B‐lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B‐cell progenitors and plasma cell precursors

    B‐lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B‐cell progenitors and plasma cell precursors 由 Andy C. Rawstron, Faith E. Davies, Roger G. Owen, Anne English, Guy Pratt, J. A. Child, Andrew Jack, Gareth J. Morgan

    出版 1998
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Diagnostic criteria for monoclonal B‐cell lymphocytosis

    Diagnostic criteria for monoclonal B‐cell lymphocytosis 由 Gerald E. Marti, Andy C. Rawstron, Paolo Ghia, Peter Hillmen, Richard S. Houlston, Neil E. Kay, Thérèse Aurran Schleinitz, Neil E. Caporaso

    出版 2005
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition 由 Maryalice Stetler‐Stevenson, Bruno Paiva, Lloyd M. Stoolman, Pei Lin, Jeffrey L. Jorgensen, Alberto Órfão, Jacques J. M. van Dongen, Andy C. Rawstron

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Minimal residual disease is an independent predictor for 10-year survival in CLL

    Minimal residual disease is an independent predictor for 10-year survival in CLL 由 Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul Evans, Sheila J.M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

    CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells are increased whilst CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup>αβTCR<sup>+</sup> Double Negative T cells are... 由 Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin, Lee Marles, Andy C. Rawstron, A. John Ashcroft, Roger G. Owen, Peter J. Selby, Gordon Cook

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

    Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion 由 Andy C. Rawstron, Martin Yuille, Julie Fuller, Matthew Cullen, Ben Kennedy, Stephen J. Richards, Andrew Jack, Estella Matutes, Daniel Catovsky, Peter Hillmen, Richard S. Houlston

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting 由 Maria Arroz, Neil Came, Pei Lin, Weina Chen, Constance M. Yuan, Anand S. Lagoo, Mariela Monreal, Ruth de Tute, Jo‐Anne Vergilio, Andy C. Rawstron, Bruno Paiva

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14)

    IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14) 由 Sylvia Feyler, Sheila J.M. O’Connor, Andy C. Rawstron, Chezhian Subash, Fiona M. Ross, Guy Pratt, Mark T. Drayson, John Ashcroft, Gordon Cook, Roger G. Owen

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases

    Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases 由 Md Yuzaiful Md Yusof, Edward M Vital, Damien McElvenny, E. Hensor, Sudipto Das, Shouvik Dass, Andy C. Rawstron, Maya H Buch, Paul Emery, Sinisa Savic

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: